相关实验视频

Updated: Jan 11, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

在EGFR突变非小细胞肺癌中的免疫疗法

Liwen Wang^1,2, Xinghong Xian^1,2, Hua Ke³

¹Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Clinical and experimental medicine

|November 17, 2025

概括

对于EGFR突变非小细胞肺癌 (NSCLC) 患者,免疫检查点抑制剂 (ICI) 的疗效有限. 需要进一步的研究来确定患者子组和改善NSCLC免疫疗法益处的策略.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
分子诊断学分子诊断学

背景情况:

皮表皮生长因子受体 (EGFR) 突变驱动非小细胞肺癌 (NSCLC) 用氨酸激酶抑制剂 (TKI) 治疗.
对EGFRTKI的获得性耐药性是常见的,因此在TKI耐药性NSCLC中,对有效疗法的关键需求尚未得到满足.
免疫检查点抑制剂 (ICI) 已经彻底改变了先进的NSCLC治疗,但它们在EGFR突变NSCLC中的有效性有限.

研究的目的:

审查目前关于ICI在EGFR突变的先进NSCLC中的疗效的临床证据.
为了确定EGFR突变NSCLC中的特定患者亚群,他们可能受益于免疫疗法.
探索新的治疗策略,以提高这种患者群体的免疫治疗结果.

主要方法:

关于临床试验和涉及NSCLCICI的研究的综合文献综述.
对EGFR突变患者免疫治疗响应率的临床数据的分析.
识别与ICI益处相关的预测生物标志物和患者特征.

主要成果:

目前的临床证据表明,标准ICI在EGFR突变NSCLC中的有效性有限.
某些EGFR突变亚群可能对免疫治疗有不同的反应.
特定突变和耐药机制在调节ICI疗效方面的作用需要进一步阐明.

结论:

免疫检查点抑制剂 (ICI) 在EGFR突变非小细胞肺癌 (NSCLC) 的第一线治疗中具有有限的作用,原因是获得了耐药性.
识别特定的EGFR突变亚群和开发新的治疗策略对于扩大免疫疗法益处至关重要.
需要进一步研究以优化EGFR突变NSCLC患者的免疫治疗方法.

关键词:

欧洲农业基金会 (EGFR) 是一个.免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.非小细胞肺癌是非小细胞肺癌.在PD-L1中.

更多相关视频

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...